Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Concise Review: Drug Discovery in the Age of the Induced Pluripotent Stem Cell

3 Feb 2014

Abstract excerpt

For decades, the paradigm of drug discovery and development has relied on immortalized cell lines, animal models of human disease, and clinical trials. With the discovery of induced pluripotent stem cell (iPSC) technology in 2007, a new human in vitro drug testing platform has potentially augmented this set of tools by providing additional ways to screen compounds for safety and efficacy. The growing number of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomedical Ethics and Regulation
Share to CRISPR and Genetic Engineering
Share to Pluripotent Stem Cells Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24493856
DOI: 10.5966/sctm.2013-0162

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Concise Review: Drug Discovery in the Age of the Induced Pluripotent Stem CellPMID 24493856Read ↗

Future perspective of induced pluripotent stem cells for diagnosis, drug screening and treatment of human diseasesSemantic proximity Read ↗

Induced Pluripotent Stem Cells as a Model for Accelerated Patient- and Disease-specific Drug DiscoverySemantic proximity Read ↗

Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discoverySemantic proximity Read ↗

Induced Pluripotent Stem Cells (iPSCs)-Roles in Regenerative Therapies, Disease Modelling and Drug Screening.Semantic proximity Read ↗

Applications of Patient-Specific Induced Pluripotent Stem Cells; Focused on Disease Modeling, Drug Screening and Therapeutic Potentials for Liver DiseaseSemantic proximity Read ↗

Recent Updates on Induced Pluripotent Stem Cells in Hematological DisordersSemantic proximity Read ↗

A Commentary on iPS Cells: Potential Applications in Autologous Transplantation, Study of Illnesses and Drug ScreeningSemantic proximity Read ↗

Concise Review: Induced Pluripotent Stem Cell Research in the Era of Precision Medicine.Semantic proximity Read ↗

Full biological characterization of human pluripotent stem cells will open the door to translational research.Semantic proximity Read ↗

New lessons learned from disease modeling with induced pluripotent stem cells.Semantic proximity Read ↗

Disease modelling using induced pluripotent stem cells: status and prospects.Semantic proximity Read ↗

Drug Development and the Use of Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Disease Modeling and Drug Toxicity ScreeningSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.